DXB vs RAD

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

40LOW

RAD

RADIOPHARM FPO [RAD]

40LOW

Score Breakdown

DXB RAD
Technical
45
55
Catalyst
48
53
Sentiment
50
50
Fundamental
82
76
Momentum
36
45
Risk Gate
50
37

Key Metrics

DXB Metric RAD
$141.1MMarket Cap$47.3M
3.2MAvg Volume (20d)4.5M
N/AShort Interest+0.0%
$0.66552-Week High$0.040
$0.15852-Week Low$0.017
+2.1%Daily Change+0.0%
$0.240Entry Price$0.020
-594.5%ROE-92.1%
-219.9%Profit Margin-286.2%

Active Signals

DXB Signals

●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-29
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (15% of range)

RAD Signals

●MACD momentum is picking up steam
●Above-average volume (1.5x) on a green day — buyers stepping up
●Volume-price trend suggests distribution — sellers may be sneaking out while price holds
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (4 quarters) - dilution risk
●Low P/S ratio (2.9x)
●Strong revenue growth (+154%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare DXB and RAD in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
DXB Full Analysis → RAD Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).